Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34312556

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Nat Med
Publication date
2021 Aug
First author
Spiegel JY

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Spiegel JY
      type
      Author
    2. name
      Patel S
      type
      Author
    3. name
      Muffly L
      type
      Author
    4. name
      Hossain NM
      type
      Author
    5. name
      Oak J
      type
      Author
    6. name
      Baird JH
      type
      Author
    7. name
      Frank MJ
      type
      Author
    8. name
      Shiraz P
      type
      Author
    9. name
      Sahaf B
      type
      Author
    10. name
      Craig J
      type
      Author
    11. name
      Iglesias M
      type
      Author
    12. name
      Younes S
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Spiegel JY
      type
      Author
    2. name
      Patel S
      type
      Author
    3. name
      Muffly L
      type
      Author
    4. name
      Hossain NM
      type
      Author
    5. name
      Oak J
      type
      Author
    6. name
      Baird JH
      type
      Author
    7. name
      Frank MJ
      type
      Author
    8. name
      Shiraz P
      type
      Author
    9. name
      Sahaf B
      type
      Author
    10. name
      Craig J
      type
      Author
    11. name
      Iglesias M
      type
      Author
    12. name
      Younes S
      type
      Author
    bibliography ids
    1. nci-bib-91020f401724f1647005142f
    book metadata
    content sha256
    dcc319ea7a88cbae93a48641fcdfea7e7b9a46221ddad1ed02dc6a9a565ca570
    document type
    citation
    dois
    1. 10.1038/s41591-021-01436-0
    electronic publication date
    display
    2021 Jul 26
    precision
    day
    year
    2021
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:34312556
    immutable id
    pubmed:34312556@dcc319ea7a88cbae93a48641fcdfea7e7b9a46221ddad1ed02dc6a9a565ca570
    journal
    abbreviation
    Nat Med
    issn electronic
    1546-170X
    issn print
    1078-8956
    issue
    8
    name
    Nature medicine
    nlm unique id
    9502015
    pages
    1419-1431
    volume
    27
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      34312556
      provenance
      batch id
      192b6392c165c6b06274
      provider
      NCBI PubMed ESummary
      record sha256
      488ac736fea4894f7a51792716dba702109499f47ba6a7a2ae90ae2c36f3b30b
      response sha256
      7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
      retrieved at
      2026-09-09T23:48:02.713075+00:00
      publication date
      display
      2021 Aug
      precision
      month
      year
      2021
      publication types
      1. Clinical Trial, Phase I
      2. Journal Article
      3. Research Support, N.I.H., Extramural
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/34312556/
      title
      CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial.

      Preserved source evidence · Not medical advice